SCHEMBL6946157

SCHEMBL6946157

CN1CCC(Cl)CC1.[MgH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364269 0.97
Hydrochloric Acid SCHEMBL490234 0.94
Hydrochloric Acid SCHEMBL28548326 0.91 NCF1 (0.40)
Ammonia Solution, Strong SCHEMBL27534524 0.91 NCF1 (0.40)
Magnesium Chloride Anhydrous SCHEMBL28548324 0.88 NCF1 (0.39)
SCHEMBL10680163 0.86
SCHEMBL21729982 0.84 LMNA (0.42)
SCHEMBL9699113 0.79
SCHEMBL140205 0.73 ALDH1A1 (0.40)
SCHEMBL7853639 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117402105-A Preparation method of cyproheptadine hydrochloride 云鹏医药集团有限公司 2024-01-16 CN claimed
CN-110407737-B Preparation method of cyproheptadine hydrochloride 广州普星药业有限公司 2021-03-23 CN claimed
CN-117402105-A Preparation method of cyproheptadine hydrochloride 云鹏医药集团有限公司 2024-01-16 CN disclosed
CN-117402105-A Preparation method of cyproheptadine hydrochloride 云鹏医药集团有限公司 2024-01-16 CN disclosed
CN-110407737-B Preparation method of cyproheptadine hydrochloride 广州普星药业有限公司 2021-03-23 CN disclosed
CN-100345843-C 4- (thioxanthene-9-subunit) -piperidine or acridine derivative and application thereof in preparation of medicines BIOFRONTERA PHARMACEUTICALS GM (DE) 2007-10-31 CN disclosed
CN-1575291-A Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist BIOFRONTERA PHARMACEUTICALS GM (DE) 2005-02-02 CN disclosed
EP-1140899-B1 PROCESS FOR PREPARING TRICYCLIC COMPOUNDS HAVING ANTIHISTAMINIC ACTIVITY SCHERING CORP (US) 2003-09-10 EP disclosed
US-6440989-B2 ANTITUMOR AGENT SCHERING CORPORATION 2002-08-27 US disclosed
EP-1140899-A1 PROCESS FOR PREPARING TRICYCLIC COMPOUNDS HAVING ANTIHISTAMINIC ACTIVITY SCHERING CORPORATION (US) 2001-10-10 EP disclosed
US-20010016585-A1 Novel phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase AFONSO ADRIANO (IN) 2001-08-23 US disclosed
WO-1989010369-A1 NOVEL BENZOPYRIDO PIPERIDINE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE AND METHODS OF USE SCHERING CORPORATION (US) 1989-11-02 WO disclosed
US-4843163-A Certain 3-(2-phenethyl)-1-carbamoyloxypyridinium halide intermediates SMITHKLINE BECKMAN CORPORATION (US) 1989-06-27 US disclosed
EP-0319254-A2 Intermediates for the production of pyridobenzocycloheptene SMITHKLINE BEECHAM CORPORATION (US) 1989-06-07 EP disclosed
EP-0000716-B1 PYRROLO(2,1-B)(3)BENZAZEPINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1983-03-09 EP disclosed
US-4195091-A Appetite stimulating pyrrolo[2,1-b][3]benzazepines MERCK & CO., INC. (US) 1980-03-25 US disclosed
US-4148903-A Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines MERCK & CO., INC. (US) 1979-04-10 US disclosed
EP-0000716-A2 Pyrrolo(2,1-b)(3)benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them MERCK & CO. INC. (US) 1979-02-21 EP disclosed
US-4020169-A FROM ARYL IODIDE OR BROMIDE AND TRIFLUOROMETHYL THIO COPPER MERCK & CO., INC. (US) 1977-04-26 US disclosed
US-3981877-A APPETITE STIMULANTS MERCK & CO., INC. (US) 1976-09-21 US disclosed